FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to organic chemistry and medicine, and concerns salts of (2S,3R-)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofurane-2-carboxamide, substantially free from (2S,3S)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofurane-2-carboxamide, (2R,3S)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofurane-2-carboxamide and (2R,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofurane-2-carboxamide.
EFFECT: preparing the compositions applicable for treating the conditions and disorders associated with central and vegetative nervous system dysfunction.
5 cl, 19 dwg, 7 tbl, 18 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 3-(HETEROARYLOXY)-2-ALKYL-1-AZABICYCLOALKYL DERIVATIVES AS LIGANDS OF ALPHA-7-nAChR (NICOTINIC ACETYLCHOLINE RECEPTORS), MEANT FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES | 2005 |
|
RU2402551C2 |
| RECEPTOR SUBTYPE-SELECTIVE AZABICYCLOALKANE DERIVATIVES | 2008 |
|
RU2417984C1 |
| INDAZOLES, BENTOTHIAZOLES, BENZOISOTHIAZOLES, BENZISOXAZOLES AND SYNTHESIS AND USE THEREOF | 2005 |
|
RU2417225C2 |
| COMBINATION OF ALPHA 7 NICOTINIC RECEPTOR AGONISTS AND ANTIPSYCHOTIC AGENTS | 2009 |
|
RU2481123C2 |
| SUBSTITUTED 3-AMINOQUINUCLIDINES | 1992 |
|
RU2092486C1 |
| DERIVATIVES OF QUINUCLIDINEAMIDE, METHOD FOR THEIR PREPARING AND THEIR USING, PHARMACEUTICAL COMPOSITION, COMBINED PRODUCT AND METHOD FOR INHIBITION OF MUSCARINIC RECEPTORS | 2003 |
|
RU2314306C2 |
| AZABICYCLIC ALKANE DERIVATIVES SUBSTITUTED WITH CONDENSED BICYCLOHETEROCYCLE | 2007 |
|
RU2437884C2 |
| INDAZOLES, BENZOTHIAZOLES, BENZOISOTHIAZOLES, BENZOISOXAZOLES, PYRAZOLOPYRIDINES, ISOTHIAZOLOPYRIDINES, PREPARING AND USING THEM | 2006 |
|
RU2450003C2 |
| LIGANDS OF NICOTINE RECEPTOR α, THEIR OBTAINING AND APPLICATION | 2005 |
|
RU2418797C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING PYRIDONE DERIVATIVES | 2012 |
|
RU2585287C2 |
